Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Benzedrine and Brain Metabolism

Abstract

THE unquestioned value of benzedrine (phenyl-isopropylamine) in the treatment of nareolepsy has made it of interest to discover in what ways this drug might influence metabolic events in the nervous system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Quastel and Wheatley, Biochem. J., 27, 1609, (1933).

    Article  CAS  Google Scholar 

  2. Pugh and Quastel, Biochem. J., 31, 286, (1937).

    Article  CAS  Google Scholar 

  3. Pugh and Quastel, Biochem. J., 31, 2308, (1937). Blaschko, Richter and Schlossmann, Biochem. J., 31, 2187, (1937).

    Google Scholar 

  4. Pugh and Quastel (unpublished).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MANN, P., QUASTEL, J. Benzedrine and Brain Metabolism. Nature 144, 943–944 (1939). https://doi.org/10.1038/144943b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/144943b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing